We will have limited operations from 15:00 Tuesday 24 December 2024 (AEDT) until Thursday 2 January 2025. Find out how to contact us during the holiday period.
Notice for thiotepa (Link Medical Products Pty Ltd)
Active ingredients
thiotepa
Sponsor
Date of review outcome
Lapse date
Type
Orphan drug
Dosage form(s)
Powder for injection/Solution for infusion
Indication
Thiotepa is indicated in combination with other chemotherapy medicinal products as conditioning treatment prior to Haematopoietic Progenitor Cell Transplantation (HPCT)
Therapeutic area
Oncocoloy